Details of the Drug

General Information of Drug (ID: DMY06PB)

• Drug Name: ASP2074

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]

• Drug Type: Antibody
• Cross-matching ID: TTD ID: DO0C7S

References

• [1] ClinicalTrials.gov (NCT05646797) A Phase 1/1b Study of ASP2074 in Participants With Metastatic or Locally Advanced Solid Tumors. U.S.National Institutes of Health.